Nanotechnology RSS feeds


ENJOY THE BENEFITS

Simply Register to GAIN ACCESS to lots more info

USER LOGIN

NANOTECHNOLOGY FACTS ...

...Nanometres...
nanotechnology companies | nanotechnology info Human hair 80,000 nm wide
nanotechnology companies | nanotechnology info Red blood cell 7,000 nm wide
nanotechnology companies | nanotechnology info Water molecule 0.3 nm wide

SALES & WANTED

nanotechnology companies | nanotechnology infoNano Silver Powder
nanotechnology companies | nanotechnology infoFree Green Engine Oil

-----
What have you? - Place your ads here for FREE - *APPLY*

LATEST MEMBERS

  • PeterGay
  • George@MaRS
  • kcchee
  • neveen.samy
  • danny004
  • dragonfly

WHO'S ONLINE

There are currently 1 user and 12 guests online.

Online users

  • Admin

  Valid XHTML 1.0 Transitional

Button for your site

Flex-Power® Joint & Muscle Pain Relief Cream

Long description :

“Flex-Power Joint & Muscle Pain Relief Cream’s active ingredient is trolamine salicylate (10%), and also contains MSM and Glucosamine. Flex-Power’s combined ingredients with nanotech delivery system is what makes it so effective.”

“Flex-Power Pain Relief Cream utilizes a nanotechnology system to deliver active ingredients for pain relief through the skin. We call this technology Flex-Somes™, which is comprised of microscopic capsules that penetrate quickly and deeply to provide long lasting relief without skin irritation.”

“Flex-Somes™ are a proprietary liposome technology, used to microscopically encapsulate nutrients and pharmaceutical ingredients. Liposomes were originally used by the pharmaceutical industry to deliver medications. Liposomes are highly complex microscopic lipid spheres. The membrane of a liposome is made of highly purified natural lecithin that encapsulates water and ingredients.”

Product's company name : Flex-Power®, Inc.

Product company Url :
http://www.flexpower.com/flex_work.html
» | Edit this entry
                                                                                                                                                                                                                                                                                          
Back to previous page Go to the top of this page